Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants
about
Repression of the A8L gene, encoding the early transcription factor 82-kilodalton subunit, inhibits morphogenesis of vaccinia virionsExpanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategiesExpression of streptococcal M protein in mammalian cells.The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.Analysis of a vaccinia virus mutant expressing a nonpalmitylated form of p37, a mediator of virion envelopment.Translational modulation of proteins expressed from bicistronic vectors.A selectable and excisable marker system for the rapid creation of recombinant poxviruses.Vaccinia virus vectors: new strategies for producing recombinant vaccines.The 35-kilodalton protein gene (p35) of Autographa californica nuclear polyhedrosis virus and the neomycin resistance gene provide dominant selection of recombinant baculoviruses.Vaccinia protein kinase 2: a second essential serine/threonine protein kinase encoded by vaccinia virus.Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis.De novo synthesis of the early transcription factor 70-kilodalton subunit is required for morphogenesis of vaccinia virions.A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9.Orthopoxvirus targets for the development of antiviral therapies.A tandemly-oriented late gene cluster within the vaccinia virus genomeThe vaccinia virus I1 protein is essential for the assembly of mature virions.Vaccinia virus B1 kinase: phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins.Plaque size phenotype as a selectable marker to generate vaccinia virus recombinantsGeneration of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25Utilization of DNA recombination for the two-step replacement of growth factor sequences in the vaccinia virus genome.Transient dominant selection of recombinant vaccinia viruses.Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors.Delineation of the viral products of recombination in vaccinia virus-infected cells.Genetically engineered poxviruses for recombinant gene expression, vaccination, and safetyThe vaccinia virus G1L putative metalloproteinase is essential for viral replication in vivo.Vaccinia virus: a tool for research and vaccine development.The molecular biology of frog virus 3 and other iridoviruses infecting cold-blooded vertebrates.The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro.Characterization of the single-stranded DNA binding protein encoded by the vaccinia virus I3 gene.An efficient method for generating poxvirus recombinants in the absence of selectionThe use of vaccinia virus for the construction of recombinant vaccines.The vaccinia virus gene I2L encodes a membrane protein with an essential role in virion entry.The target DNA sequence for resolution of poxvirus replicative intermediates is an active late promoter.Construction of fowlpox virus vectors with intergenic insertions: expression of the beta-galactosidase gene and the measles virus fusion gene.Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.Vaccinia virus uracil DNA glycosylase interacts with the A20 protein to form a heterodimeric processivity factor for the viral DNA polymerase.Use of the gene encoding neomycin phosphotransferase II to convect linked markers into the vaccinia virus genomeGeneticin (G418) resistance and electroporation-mediated transformation of Fusarium graminearum and F. culmorum.Vaccinia virus A12L protein and its AG/A proteolysis play an important role in viral morphogenic transition.
P2860
Q32157318-3E82708C-901F-409A-9A34-4A38C6D2C837Q33440600-5D75349E-E3B0-4E6B-829A-CBC34627CE6AQ33637094-0F023CE1-3540-42A5-B53C-AE4C54BCF3D0Q33782803-1E463715-3ECE-400A-A0FC-34580DE63C5FQ33784474-17FAF1B5-2FC4-4B2D-A163-D176E3BB9618Q33827935-5EAA8C11-1B90-4679-A8AF-4D46EBC1798EQ34023827-8E0D7A56-B905-4013-9216-52F30132540FQ34211635-B3115F6A-50D1-46E8-9D8D-839741CDF109Q34979885-B91B2FC0-CACB-4F95-8D77-D32913055B0CQ35654900-A98F23BE-DC09-40B7-B32D-EF04E1E45C35Q35859887-84B16291-E80F-4B05-A007-8D50393C687CQ35871988-68AD376B-52EC-4B7F-8975-48B75941BCEAQ36064702-B6E43202-2346-44CD-B42D-CDF49E917908Q36074391-71E0D895-CEA9-4BCE-8205-F70BDEAB27A7Q36095757-3E44698A-D9A0-4421-AD4E-BBF31B52FCDAQ36548814-D5F0F68C-B12D-4392-9E98-565AABA9582AQ36699027-761CFA10-F177-4997-89C2-64BA4E95F0F6Q36781179-D94CB770-5089-4CBF-A004-5C26F7444B5AQ36796061-B4D5F909-9B73-4035-8217-F609EB18C422Q36796095-925D09DA-6A0F-4E5D-B834-FA2797BBDDE6Q36797598-FD3852A8-E3D8-4873-814E-659622F64F28Q36808769-122B382D-DE03-49A2-AD3A-7942FA175AD1Q36868255-737347B0-2F51-4B0D-A235-7699738C890BQ36876770-65DA3433-D203-4168-8505-A95B31548DE8Q37249251-8F9A56E0-3705-4273-9B20-A8E3DDAF3BF8Q37492792-9A8E90B5-FF50-46BA-AA77-4AB3985F31F3Q37755852-9FAAEF73-EF32-464A-8409-B3CF1A60D440Q37954258-351262F9-AE36-400A-9446-BE1A56ABFED7Q38288824-E97FF2E0-C8B8-4615-BE19-154407E27BABQ38338835-C5EDFE73-CFAE-43EF-B90E-48B92D20815BQ39558525-57399033-BFCA-4433-832B-D8091C9D1708Q39763601-569C037F-4D4D-4999-9519-DA8661AC9674Q39950913-B022046A-6B96-41ED-A3E5-F7401EF20733Q40062469-93E336B5-7E9D-4D79-95FB-D0F634CEE7F3Q40107685-DF9A4E5A-1EE9-4EA5-BE29-716C673CDFCDQ40116789-CFF157A0-239F-47A8-BA6E-F5888B31099DQ40344000-A7E00123-ED11-46DB-8138-3AC57A5984FDQ40544596-84CA56DA-A359-4A04-8EB6-5484C4543CE3Q40742088-CE615EF1-9F55-4BA0-A3E7-87CBBE6431DAQ42416055-D13E33AB-76D4-4AB1-932C-CCE087385F5B
P2860
Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Neomycin resistance as a domin ...... of vaccinia virus recombinants
@en
type
label
Neomycin resistance as a domin ...... of vaccinia virus recombinants
@en
prefLabel
Neomycin resistance as a domin ...... of vaccinia virus recombinants
@en
P2093
P2860
P356
P1476
Neomycin resistance as a domin ...... of vaccinia virus recombinants
@en
P2093
P2860
P304
P356
10.1128/MCB.5.8.1918
P407
P577
1985-08-01T00:00:00Z